Contineum Therapeutics CTNM
NASDAQ CTNM
$8.45 -0.01 (-0.12%)
As of: Oct 21, 2026 · 2:52 PM EDT

Contineum Therapeutics (CTNM) Tax Rate (2023)

Updated

Contineum Therapeutics (CTNM) recorded Tax Rate of 2.03% in Q4 2023, up 0.18 percentage points from the prior quarter.

Analysis

Contineum Therapeutics (CTNM) Tax Rate (2023) Analysis & Trends

For FY2023, Contineum Therapeutics reported Tax Rate of 1.94%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 17.98%
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn 15.47%
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn -
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 23.71%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 10.40%
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn 14.20%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn -
10 Contineum Therapeutics 320.72 Mn -607.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.72%
API Access

Contineum Therapeutics Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=CTNM&period=max&api_key=YOUR_API_KEY